Artículo Original
169
Referencias
1.- Zhang M. High antibiotic resistance
rate: A difficult issue for Helicobacter
pylori eradication treatment. World J
Gastroenterol 2015; 21: 13432-7.
2.- Malfertheiner P, Megraud F, O’Morain
C, Bazzoli F, El-Omar E, Graham D,
et al. Current European concepts in the
management of Helicobacter pylori
infection. The Maastricht Consensus
Report. European Helicobacter pylori
Study Group. Gut 1997; 41: 8-13.
3.- Graham DY, Fischbach L. Helicobacter
pylori treatment in the era of increasing
antibiotic resistance. Gut 2010; 59:
1143-53.
4.- Liou JM, Fang YJ, Chen CC, Bair MJ,
Chang CY, Lee YC, et al. Concomitant,
bismuth quadruple, and 14-day triple
therapy in the first-line treatment of
Helicobacter pylori: a multicentre,
open-label, randomised trial. Lancet
2016; 388: 2355-65.
5.- Ghotaslou R. Prevalence of antibiotic
resistance in Helicobacter pylori:
A recent literature review. World J
Methodol 2015; 5: 164.
6.- Greenberg ER, Anderson GL, Morgan
DR, Torres J, Chey WD, Bravo LE, et al.
14-day triple, 5-day concomitant, and
10-day sequential therapies for
Helicobacter pylori infection in seven
Latin American sites: A randomised trial.
Lancet 2011; 378: 507-14.
7.- Riquelme A, Soza A, Pedreros C,
Bustamante A, Valenzuela F, Otarola F, et
al. Optimal length of triple therapy
for H. pylori eradication in a population
with high prevalence of infection in
Chile. World J Gastroenterol 2007; 13:
2967-72.
8.- Camargo MC, García A, Riquelme A,
Otero W, Camargo CA, Hernández-
García T, et al. The problem of
Helicobacter pylori resistance to
antibiotics: a systematic review in Latin
America. Am J Gastroenterol 2014; 109:
485-95
9.- Salinas A, Orosco J, Rivera C,
Mezzano G, Montenegro C, Rojas R
et al. Detección de la resistencia del
Helicobacter pylori a la claritromicina
mediante nueva técnica de biología
molecular (Abstract). Gastroenterol
latinoam 2015; 26 Supl 2: S95-S96.
10.- González-Hormazábal P, Castro VG,
Musleh M, Lanzarini L, Valladares H,
Escandar S, et al. Alta prevalencia de
cepas de resistentes a claritromicina.
Experiencia del Hospital Clínico de
la Universidad de Chile. (Abstract).
Gastroenterol latinoam 2016; 27 Supl 2:
S143.
11.- Smith S, Boyle B, Brennan D, Buckley
M, Crotty P, Doyle M, et al. The Irish
Helicobacter pylori Working Group
consensus for the diagnosis and treatment
of H. pylori infection in adult patients
in Ireland. Eur J Gastroenterol Hepatol
2017; 29: 552-9.
12.- Gisbert JP, Romano M, Molina-Infante
J, Lucendo AJ, Medina E, Modolellet
I, et al. Two-week, high-dose proton
pump inhibitor, moxifloxacin triple
Helicobacter pylori therapy after failure
of standard triple or non-bismuth
quadruple treatments. Dig Liver Dis
2015; 47:108-13.
13.- Malfertheiner P, Megraud F, O’Morain
C, Bazzoli F, El-Omar E, Graham D, et
al. Current concepts in the management
of Helicobacter pylori infection: the
Maastricht III Consensus Report. Gut
2007; 56: 772-81.
14.- Shaikh T, Fallone CA. Effectiveness
of second through sixth line salvage
Helicobacter pylori treatment: bismuth
quadruple therapy is almost always a
reasonable choice. Can J Gastroenterol
Hepatol 2016; 2016: 7321574.
15.- Sugano K, Tack J, Kuipers EJ,
Graham DY, El-Omar EM, Miura S, et
al. Kyoto global consensus report on
Helicobacter pylori gastritis. Gut 2015;
64: 1353-67.
16.- Lee HJ, Kim J Il, Lee JS, Jun EJ, Oh
JH, Cheunget DY, et al. Concomitant
therapy achieved the best eradication
rate for Helicobacter pylori among
various treatment strategies. World J
Gastroenterol 2015; 21: 351-9.
17.- Chey WD, Moayyedi P. Review article:
uninvestigated dyspepsia and non-ulcer
dyspepsia-the use of endoscopy and the
roles of Helicobacter pylori eradication
and antisecretory therapy. Aliment
Pharmacol Ther 2004;19 Suppl 1: 1-8.
18.- Zhao B, Zhao J, Cheng WF, Shi WJ,
Liu W, Pan XL, et al. Efficacy of
Helicobacter pylori eradication therapy
on functional dyspepsia: a meta-analysis
of randomized controlled studies with
12-month follow-up. J Clin Gastroenterol
2014; 48: 241-7.
19.- Song ZQ, Zhou LY. Hybrid, sequential
and concomitant therapies for
Helicobacter pylori eradication: A
systematic review and meta-analysis.
World J Gastroenterol 2016; 22: 4766-75.
Erradicaci ón de H. pylori con terapia concomi tan te - M. P. R ollán M. et al.
Gastroenterol. latinoam 2017; Vol 28, Nº 3: 165-169